Comparison of the acute-phase response in patients with ischemic stroke treated with high-dose heparin or aspirin
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 178 (1) , 17-22
- https://doi.org/10.1016/s0022-510x(00)00345-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic strokePublished by Elsevier ,1997
- Reduction of brain injury using heparin to inhibit leukocyte accumulation in a rat model of transient focal cerebral ischemia. I. Protective mechanismJournal of Neurosurgery, 1996
- Reduction of brain injury using heparin to inhibit leukocyte accumulation in a rat model of transient focal cerebral ischemia. II. Dose—response effect and the therapeutic windowJournal of Neurosurgery, 1996
- Heparin-Like Glycosaminoglycans Inhibit Leukocyte Adhesion to Endotoxin-Activated Human Vascular Endothelial Cells under Nonstatic ConditionsEuropean Surgical Research, 1996
- Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Early Intrathecal Production of Interleukin-6 Predicts the Size of Brain Lesion in StrokeStroke, 1995
- Early Prediction of Stroke SeverityStroke, 1995
- A comparison of five stroke scales with measures of disability, handicap, and quality of life.Stroke, 1993
- The Stroke Data Bank: design, methods, and baseline characteristics.Stroke, 1988
- DOUBLE-BLIND EVALUATION OF GLYCEROL THERAPY IN ACUTE CEREBRAL INFARCTIONThe Lancet, 1972